Showing 141 - 150 of 65,787
We use data of antidepressants prescribed by general practices to investigate the impact of COVID-19 on mental health … general practice health services caused by the pandemic. For this, we construct a counterfactual group using prescription data …
Persistent link: https://www.econbiz.de/10014084540
While the long-term consequences of unmet child mental health needs are well-documented, out-of-pocket costs remain an … results suggest that reductions in out-of-pocket costs could help achieve better uptake of mental health treatment, without … insurance program in Québec, Canada, to estimate the impact of out-of-pocket costs on uptake of pharmaceutical treatment for …
Persistent link: https://www.econbiz.de/10013296644
Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality information. The FDA's Breakthrough Therapy Designation (BTD) provides an opportunity to understand if a regulator can use new policy to innovate around this...
Persistent link: https://www.econbiz.de/10013477204
treatment costs were calculated for patients covered under Medicare Part B and D. The association between log-prices and …
Persistent link: https://www.econbiz.de/10014357763
Persistent link: https://www.econbiz.de/10014357841
Vaccinations against life-threatening diseases are one of the greatest public health achievements in history. Literally … individualism, misinformation about risk, and overperception of risk. State legislatures and health departments thus face a … have already occurred. Lawsuits against vaccine manufacturers threaten them with bankruptcy, costs are being externalized …
Persistent link: https://www.econbiz.de/10014066065
countries, including vaccine deliveries, demographic structure, health and transport infrastructure and development level. It …
Persistent link: https://www.econbiz.de/10014264530
Forty percent of spiraling US drug costs are based on a mere two percent of all drugs –biologic drugs (biologics) made … from living cells that are administered by injection or infusion. These costs will continue to balloon as new biologics are … allowed by an expedited regulatory approval process that lowers the costs of obtaining regulatory approval. However, US …
Persistent link: https://www.econbiz.de/10014087594
evidence of rising research and clinical testing costs underlying pharmaceutical innovations. There is a general concurrence …) how to control the costs and prices of new innovative drugs; (iii) how to direct more innovation to areas where social …
Persistent link: https://www.econbiz.de/10013028133
Competition among health insurers is widely considered to be a means of enhancing efficiency and containing costs in … the health care system. In this paper, it is argued that this could be unsuccessful since health care providers hold a … strong position on the market for health care services. Physicians exert a type of monopolistic power which can be described …
Persistent link: https://www.econbiz.de/10010271400